Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome
Authors: Weiskopf et al.
Journal/ Pre-Print: medRxiv
Key Words: T cells; antigen-specific; Th1; spike protein
1. SARS-CoV-2 surface glycoprotein S is a potent T cell immunogen
2. SARS-CoV-2 specific CD4+ T cells in the blood of severe COVID-19 patients are mostly central memory cells.
3. The cytokine profile observed upon re-stimulation of PBMCs is dominated by Th1 cytokines (IFNg, TNFa and IL-2), while Th2 cytokines and Th17 cytokines were only observed at low levels. Of note, an increase in IL-6 is not observed upon stimulation suggesting that IL-6 is predominantly secreted by innate immune cells.
This preprint assessed the phenotype of SARS-CoV-2 specific T lymphocytes in 8 patients admitted to intensive care (age average 59; mixed genders). Levels of virus-specific IgG and spike protein-specific CD4+ T cells increased over time since ICU admission. More lymphocytes became activated by peptide pools generated from the SARS-CoV-2 spike protein than other viral proteins, suggesting enhanced immunogenicity of the spike protein. This work also shows that SARS-CoV-2-specific CD4 T cells were predominantly of the central memory subset. Their activation was associated with the secretion of Th1-associated cytokines such as IFNg, TNFa and IL-2.
IMPACT FOR SARS-COV2/COVID19 RESEARCH EFFORTS
A better understanding of the T cell immune response to SARS-CoV2/COVID19
· Patient Case study
STRENGTHS AND LIMITATIONS OF THE PAPER
Novelty: SARS-CoV-2 spike protein peptides are the target for T cell responses, the differentiation status of Ag-specific CD4+ T cells and the cytokine secretion profile of patient PBMC.
Standing in the field: Similar immunophenotyping papers have been published in China
Appropriate statistics: Yes, for cytokine and activation data (but could be more powered). No statistics for the T cell differentiation status data.
Viral model used: PBMCs from patients tested SARS-CoV-2 positive by RT-PCR were stimulated with peptide pools generated by predicting the epitopes of the SARS-CoV-2 virus based on GenBank reference data.
Translatability: Vaccine design
Main limitations: The results represent a snapshot of the circulating immune system after at least 14 days in the ICU in a relatively small number of patients. No correlation of disease progression with T cell differentiation or composition dynamics. They also assess the differentiation status of CD8 T cells and claim them to be generally more effector-like. However, the only pie chart they are providing to support this claim does not really show a very significant shift towards one predominant phenotype and any supporting statistics are also missing.